Ayesha Javed*

Department of Biotechnology, St. Francis College for Women, India

*Corresponding Author: Ayesha Javed, Department of Biotechnology, St. Francis College for Women, India.

Received: November 28, 2022; Published: December 22, 2022

Introduction

Cancer is one of the biggest causes of death, with more than 10 million mortalities annually, as reported in GLOBOCAN 2020 [1]. The most common types of cancer, according to WHO, are lung, breast, rectum, colon, and prostate cancers [2]. The essential characteristics of cancer are interlaced with an altered cancer-cell intrinsic metabolism, that maybe be the reason or an after-effect [3].

References

1. Sung H., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA Cancer Journal for Clinicians 3 (2021): 209-249.
2. Cancer (2022).
3. Zaimy MA., et al. “New methods in the diagnosis of cancer and gene therapy of cancer-based on nanoparticles”. Cancer Genetic Therapy6 (2017): 233-243.
4. Turkbey B., et al. “Functional and Molecular Imaging: Applications for Diagnosis and Staging of Localised Prostate Cancer”. Clinical Oncology8 (2013): 451-460.
5. Siegel DA., et al. “Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001-2017” (2020).
6. Sung H., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA Cancer Journal for Clinicians3 (2021): 209-249.
7. Barba D., et al. “Breast cancer, screening and diagnostic tools: All you need to know”. Critical Reviews in Oncology/Hematology 157 (2021): 103174.
8. Wu L and Qu X. “Cancer biomarker detection: recent achievements and challenges”. Chemical Society Reviews 10 (2015): 2963-2997.
9. Wadowska K., et al. “Genetic Markers in Lung Cancer Diagnosis: A Review”. International Journal of Molecular Sciences 21 (2020): 4569.
10. Hasan S., et al. “Advances in pancreatic cancer biomarkers”. Oncology Review1 (2019): 69-76.
11. Chaturvedi VK., et al. “Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy”. Current Drug Metabolism 6 (2019): 416-429.
12. Zhang Y., et al. “Nanotechnology in cancer diagnosis: progress, challenges and opportunities”. Journal of Hematology and Oncology 1 (2019): 137.
13. Kabir KMM and Donald WA. “Cancer breath testing: a patent review”. Expert Opinion on Therapeutic Patents3 (2018).
14. Tian X., et al. “CRISPR/Cas9-An evolving biological tool kit for cancer biology and oncology”. npj Precision Oncology 8 (2019).
15. Saba T. “Recent advancement in cancer detection using machine learning: Systematic survey of decades, comparisons and challenges”. Journal of Infection and Public Health 9 (2020): 1274-1289.
16. Wu D., et al. “Cancer bioinformatics: A new approach to systems clinical medicine” (2012).
17. Vandenbrouck Y., et al. “Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer”. Proteomics 21-22 (2019): 1800489.
18. Surman M and Janik ME. “Stress and its molecular consequences in cancer progression”. Postepy higieny I Medycyny Doswiadczalnej (Online) 71 (2017): 485-499.

Citation

Citation: Ayesha Javed. “Cancer: Diagnosis, Staging, and Complication".Acta Scientific Biotechnology 4.1 (2023): 20-22.

Copyright

Copyright: © 2022 Ayesha Javed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.